Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous versus peripheral intravenous Clinimix N9G15E in elderly patients at risk for malnutrition
2007-006153-31Phase 3Completed
- Sponsor
- Baxter International Inc.
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Clinimix N9G15E in Malnutrition (2 arms), sponsored by Baxter International Inc. Primary endpoint: Major local side effects. Started Mar 2008; status: completed.
02
Drugs
Clinimix N9G15E
03
Conditions
Malnutrition
Beyond the preview
Go deeper on 2007-006153-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006153-31.